bioRxiv Science⌕ Search

bioRxiv · 10.64898/2026.07.20.739621

Widely used GWAS methods can be poorly suited to SNP-level localization under diffuse polygenic architecture in livestock

Abstract

In livestock populations, genome-wide association studies (GWAS) can produce strong, apparently localized associations even when no truly discrete nearby causal effect exists. This occurs because small effective population sizes, strong family structure, long-range linkage disequilibrium (LD), and diffuse polygenic architecture can cause the effects of many variants to accumulate and be captured jointly across broad genomic intervals, making variant-level associations difficult to interpret biologically. Using real pig genotypes, we constructed a benchmark in which phenotypes were simulated under diffuse polygenic architecture across a genome partitioned into alternating effect and null windows, with central-null regions (at least 1 Mb away from effect-containing regions) positioned to detect long-range LD-driven signal propagation. We evaluated nine configurations of six GWAS methods (BOLT-LMM, REGENIE, fastGWA, FarmCPU, BLINK, and SLEMM) under this architecture. The central finding is that strong associations, of the kind normally read as evidence of nearby moderate- or large-effect variants, are produced by many of these methods even though the simulated signal is distributed across many tiny effects and cannot be localized to any single variant. The methods differed sharply in the extent of locus-level spillover: several produced large numbers of genome-wide significant loci within central-null regions, whereas the full-GRM mixed-model benchmark (SLEMM) produced no genome-wide significant loci in central-null regions. These results show that, under a highly polygenic architecture with livestock-like LD, GWAS tool choice has major consequences for biological interpretation. When the goal is to localize biologically meaningful signals rather than to flag association peaks that may merely reflect tiny effects accumulated through LD across a broad block, methods that control long-range LD spillover should be prioritized.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

Wang, X., Wang, J., Tiezzi, F., Huang, Y., Huang, W., Maltecca, C., Jiang, J.. 2026-07-23. Widely used GWAS methods can be poorly suited to SNP-level localization under diffuse polygenic architecture in livestock. https://doi.org/10.64898/2026.07.20.739621

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related preprints

OPA1 controls mitochondrial dysfunction-driven liver fibrosis in MASLD

Progressive hepatic fibrosis is the principal determinant of morbidity and mortality in metabolic dysfunction-associated steatotic liver disease and steatohepatitis (MASLD/MASH). Mitochondrial dysfunction is a hallmark of MASH, and the release of mitochondrial damage-associated molecular patterns (mito-DAMPs) from injured hepatocytes can promote fibrosis. However, how mitochondrial dynamics and quality control shape the fibrotic response in MASLD/MASH remains unclear. Here, through large-scale genomic analyses of mitochondrial genes governing mitophagy, fusion and fission in human MASLD, with a power-equivalent sample size of approximately 700,000 individuals, we identify a strong association between hepatic fibrosis and the mitochondrial fusion factor dynamin-like GTPase optic atrophy 1 (OPA1). OPA1 transcripts and protein abundance in the liver epithelium were progressively dysregulated with advancing fibrosis. In mice, hepatocyte-specific OPA1 loss alone was sufficient to induce hepatic stellate cell activation and fibrosis in zone 3, promoted the release of mito-DAMPs into the circulation and exacerbated fibrosis in experimental MASH. These findings identify OPA1 as a central regulator of the hepatic fibrotic response and connect defective mitochondrial homeostasis to mito-DAMP release, hepatic stellate cell activation and fibrosis in MASLD.

genetics↗

Temporal control of mitochondrial mutagenesis reveals the fate of mtDNA mutations with age

Mutations in the mitochondrial genome (mtDNA) play a critical role in the aging process and a wide variety of age-related diseases. However, it remains unclear when the mutations that drive physiological decline arise. To answer this question, we generated a new mouse model in which mitochondrial mutagenesis can be confined to a defined window of time. Surprisingly, we found that mutations that arise during the first two months of life are sufficient to drive a wide variety of age-related pathologies, and that the severity of this pathology is broadly regulated by distinct, tissue-specific selective pressures that control the fate of mtDNA mutations with age. Further, we found that selection against deleterious variants can be modulated by manipulation of mitochondrial fusion in vitro and in vivo. These observations raise the possibility that in some tissues, the pace of aging is pre-determined by events that occur early in life and that interventions targeting mitochondrial fusion may be able to slow down or reverse the expansion of these pathogenic variants. These results carry far-reaching implications for strategies aimed at preventing or delaying age-related decline.

genetics↗

Innate immune stress pathway activation underlies heterochromatin dysfunction pathology

Heterochromatin loss disrupts nuclear architecture, gene regulation and repetitive element silencing, and is associated with diverse human diseases. However, mechanisms linking heterochromatin dysfunction to pathological phenotypes remain unclear. Using genetic interaction screening and genomic analyses in C. elegans, we identify secondary activation of the Intracellular Pathogen Response (IPR), an innate immune stress pathway, as a major contributor to heterochromatin mutant phenotypes. Constitutive IPR activation phenocopies slow growth and indirect transcriptional changes observed in these mutants. Depletion of genetic enhancers further increased, whereas suppressor RNAi attenuated IPR activation, with direct heterochromatin targets remaining substantially deregulated. Notably, many suppressors encode active chromatin components, and mild reduction of RNA polymerase II activity ameliorates growth defects in C. elegans HP1 mutants and human HP1-deficient cells. Our findings reveal secondary stress response activation as an important mechanism linking heterochromatin dysfunction to pathology and identify transcriptional dampening as a potential therapeutic strategy for mitigating these effects.

genetics↗